STUDY ON CHANGES IN CONCENTRATION AND PROGNOSTIC VALUE OF PLASMA NGAL IN PATIENTS ACUTE KIDNEY INJURY ASSOCIATED WITH ACUTE PANCREATITIS

Hữu Nhượng Lê, Trung Kiên Nguyễn, Việt Thắng Lê

Main Article Content

Abstract

Subjects and methods: Prospective descriptive study, comparing 3 groups of subjects: 51 patients acute pancreatitis associated with acute kidney injury, 168 patients acute pancreatitis without acute kidney injury and 35 healthy people as healthy controls at Bach Mai Hospital, from October 2021 to June 2023. Result: - Among 51 patients acute pancreatitis associated with acute kidney injury, 47.1% were stage 1; 33.3% stage 2; 19.6% stage 3. - Plasma NGAL concentration of the acute pancreatitis group with acute kidney injury (570.9 ng/mL) was higher than the group without acute kidney injury (400.6ng/mL) and both were greater than the healthy control group (234.3ng/mL), the difference is statistically significant. - The median value of plasma NGAL gradually increases with the stages of acute kidney injury, the difference is statistically significant. - The cutoff point of plasma NGAL 504.29 ng/mL gave a sensitivity of 60.8% and a specificity of 68.4% (AUC = 0.684; p < 0.001) in predicting acute kidney injury in patients with pancreatitis. - The cutoff point of plasma NGAL is 486.03 ng/mL with a sensitivity of 66.1% and a specificity of 66.4% (AUC=0.651; p<0.005) in predicting the severity of acute pancreatitis. Conclusion: Plasma NGAL levels are elevated and have prognostic value in patients with acute pancreatitis and acute kidney injury. Plasma NGAL biomarkers should be used to predict acute kidney injury in patients with acute pancreatitis.

Article Details

References

1. E. T. Uğurlu, M. Tercan (2022), "The role of biomarkers in the early diagnosis of acute kidney injury associated with acute pancreatitis: Evidence from 582 cases", Ulus Travma Acil Cerrahi Derg. 29(1): 81-93.
2. T. I. Nassar, W. Y. Qunibi (2019), "AKI Associated with Acute Pancreatitis", Clin J Am Soc Nephrol. 14(7): 1106-1115.
3. A. Brewin, S. Sriprasad, andB. Somani (2022), "The Use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic and Prognostic Biomarker in Urinary Tract Obstruction: a Systematic Review", Curr Urol Rep. 23(8): 155-163.
4. S. Chakraborty, S. Kaur, V. Muddana, et al. (2010), "Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis", Am J Gastroenterol. 105(9): 2050-9.
5. A. Khwaja (2012), "KDIGO clinical practice guidelines for acute kidney injury", Nephron Clin Pract. 120(4): c179-84.
6. P. A. Banks, T. L. Bollen, C. Dervenis, et al. (2013), "Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus", Gut. 62(1): 102-11.
7. L. Yuan, X. Jin (2023), "Predictive Value of Serum NGAL and β2 Microglobulin in Blood and Urine amongst Patients with Acute Pancreatitis and Acute Kidney Injury", Arch Esp Urol. 76(5): 335-340.
8. R. Chauhan, N. Saxena, N. Kapur, et al. (2022), "Comparison of modified Glasgow-Imrie, Ranson, and Apache II scoring systems in predicting the severity of acute pancreatitis", Pol Przegl Chir. 95(1): 6-12.